Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Dr. Sarah Tolaney

Advertisement

Articles by Dr. Sarah Tolaney

Image of Tolaney

Your Tumor's Genetic Profile May Not Change Which Treatment Works Best for TNBC

ByDr. Sarah Tolaney
June 12th 2026

New ASCO data show a TNBC drug combo works for nearly all patients no matter their tumor's genetic profile.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CURE

    1

    From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma

    2

    FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma

    3

    Why Cancer Survivorship Can Be the Hardest Part, Psychologist Says

    4

    A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia

    5

    Long-Term Data From COMMANDS Trial Show Reblozyl May Help Patients With Lower-Risk MDS Live Longer

    • About Us
    • Advertise / Support
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • TargetedOnc.com
    • OncLive.com
    • OncNursingNews.com
    • Terms & Conditions
    • Privacy
    • Do Not Sell My Information
    • Washington My Health My Data
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.